Company: JUNS
Filing Date: 2025-10-27
Form Type: 8-K
Source: 0001493152-25-019783
Chunk: 5

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-27
Form: 8-K
Item: Item 1.01
Chunk 5
---
 in its sole discretion. The term “ Advance Date” is defined in the SEPA to
mean the first trading day after the expiration of the applicable Pricing Period for an Advance. In respect of any Installment
Amount, or portion thereof, to be repaid by the Company in cash, the Company must pay such Installment Amount to Yorkville by wire
transfer of immediately available funds in cash on or before such Installment Date (each, a “ Cash Repayment”). If the
Company elects an Advance Repayment for all or a portion of an Installment Amount, then the Company must deliver an Advance Notice
to Yorkville in the amount of the Installment Amount, without the Payment Premium, in accordance with the terms and conditions of
the SEPA, that will have an Advance Date on or before the applicable Installment Date. Upon the closing of such Advance Notice in
accordance with the SEPA, Yorkville will offset the amount due to be paid by Yorkville to the Company under the SEPA against an
equal amount of the Installment Amount, without the Payment Premium, to be paid by the Advance Repayment. If on the Installment Date
any portion of the Installment Amount remains unpaid, the Company must repay such outstanding Installment Amount as a cash repayment
in accordance with this Section.

For
so long as any amounts remain outstanding under either of the Convertible Notes, or unless otherwise agreed by Yorkville, if the Company
delivers an Advance Notice under the SEPA, the Company will be deemed to have elected an Advance Repayment under the Convertible Notes
in respect of such Advance Notice up to the Installment Amount which may or may not be due on an upcoming Installment Date, or subsequent
Installment Dates, until all of the outstanding amounts under both Convertible Notes have been fully repaid. Therefore, until both of
the Convertible Notes have been fully repaid, all proceeds from all advances made under the SEPA will be used solely to repay outstanding
amounts under the Convertible Notes, unless Yorkville agrees otherwise. Thereafter, the net proceeds under the SEPA to the Company will
depend on the frequency and prices at which the Company sells its Common Stock to Yorkville in one or more Advances under the SEPA, and
the Company expects that any proceeds received from such sales to Yorkville in one or more Advances under the SEPA will be used primarily
to support its Phase 2 trial of its lead asset, JOTROL,